IP Conference - 2017

Bridging the Gap Workshop – How to connect science and business within the technology transfer organization

6 October, 2018 Saturday (morning session)

 

Instructor:


Tamar Raz, CEO  Hadasit Medical Research Services and Development Ltd., Jerusalem

https://www.linkedin.com/in/tamar-raz-34b4891/



Christopher Noble, Director of Corporate Engagement Environmental Solutions Initiative MIT and AUTM Board of Directors, Boston

https://www.linkedin.com/in/crnoble/



Prof. Cengizhan Öztürk, Bogazici University BioMedical Engineering; Coordinator, Inovita & ISEK

https://www.linkedin.com/in/cengizhanozturk/




Successful technology transfer means translating the academic research into commercial results that benefit society. This is usually  a long road that is fraught with pitfalls.

A particular technology or discovery may be lauded by scientists the world over and its merits touted in the most prestigious scientific journals. But this doesn't mean that the technology is ready for industry; scientific success does not immediately translate into market success. Before an innovation can be brought to the marketplace there is an intermediate stage, a maturation or incubation stage during which ideas are cultivated and technologies are developed toward commercial products. While the research stage is funded by academic research grants and the industrial development stage is funded by companies and businesses, this intermediate stage lacks any kind of structured funding mechanisms. It's difficult to convince businesses and venture capitalists to fund this stage. At issue are the early stages of high-risk technologies without business models. This stage, often  referred  to as the "Valley of Death", is the place where great ideas go to die.

In this work shop we will learn about the vehicles technology transfer organizations use to support this intermediate stage, including:

  • Support offered through governmental funds
  • Sponsored research by industrial partners
  • Academia and hospital dedicated funds   
  • Venture Funds
  • Spinout companies

Workshop participants will be asked to bring their own cases of where they are trying to bridge this gap and their specific challenges.